TABLE 1.
Clinical samples of tissue multi arrays.
| Characteristics | Number of patients | Positive rate of CCNYc |
| Patient age, years | ||
| 0–60 | 36 | 0.30 (11/36) |
| >60 | 39 | 0.44 (17/39) |
| Gender | ||
| Male | 47 | 0.42 (20/47) |
| Female | 28 | 0.28 (8/28) |
| Histologic type | ||
| SCC1 | 30 | 0.44 (13/30) |
| Adenocarcinoma | 30 | 0.37 (11/30) |
| Large-cell carcinoma | 3 | 0.33 (1/3) |
| Bronchioloalveolar carcinoma | 5 | 0 (0/5) |
| Adenocarcinoma-SCC | 7 | 0.43 (3/7) |
| Histological grade2 | ||
| I | 8 | 0 (0/8) |
| II | 38 | 0.39 (15/38) |
| III | 19 | 0.47 (9/19) |
| Lymph node status2 | ||
| Negative | 6 | 0.33 (2/6) |
| Positive | 58 | 0.40 (23/58) |
| Distant Metastasis | ||
| Negative | 75 | 0.37 (28/75) |
| Positive | 0 | – |
| TNM Stage2 | ||
| Stage I–II | 6 | 0.33 (2/6) |
| Stage II–III | 58 | 0.40 (23/58) |
1Squamous cell carcinoma. 2The characteristic of a few clinical samples was unclear.